Raks Pharma Private Limited, a active private limited company, was established on 22 October 2008 in Ahmedabad, Gujarat, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24233GJ2008PTC068526. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.75 Cr and a paid-up capital of ₹1.62 Cr.
It upholds a compliant status. Employing 467 professional, Its leadership includes Rajeev Midha (Director), Suresh Punambhai Patel (Director), Rahul Maitra (Director). Past directors included Rajeev Midha, Kanwal Pushkarnath Pandita, Nikunj Bansibhai Patel. It holds no open charges and ₹16.76 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 901-911 Iscon Elegance, Opp. Karnavati Club, S.G.Highway,, Ahmedabad, Gujarat, 380015.
U24233GJ2008PTC068526
068526
22 October 2008
₹1.75 Cr
₹1.62 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Raks Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajeev Midha | Director | 25 Jan 2019 | Current |
| Suresh Punambhai Patel | Director | 30 Jul 2010 | Current |
| Rahul Maitra | Director | 14 May 2024 | Current |
| Sandeep Radhakisan Raktate | Director | 14 May 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 05 Apr 2019 | Past |
| Pramod Abcsdd | Director | 25 Jan 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 01 Sep 2010 | Past |
| Pramod Abcsdd | Director | 30 Jul 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Raks Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 67.09% increase. The company also saw a substantial improvement in profitability, with a 409.03% increase in profit. The company's net worth Soared by an impressive increase of 119.34%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Raks Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹167,600,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Feb 2010 | Union Bank Of India | ₹16.76 Cr | Satisfied |
Explore comprehensive loan charge details -
Raks Pharma has a workforce of 467 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Raks Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raks Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Raks Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Rahul Maitra was appointed as a Director was appointed as a Director on 14 May 2024 & has been associated with this company since 1 year 6 months . was documented.
Progress on Sandeep Radhakisan Raktate was appointed as a Director was appointed as a Director on 14 May 2024 & has been associated with this company since 1 year 6 months . was documented.
Raks Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
The activity Rajeev Midha was appointed as a Director was appointed as a Director on 25 Jan 2019 & has been associated with this company since 6 years 10 months . was completed.
A charge registered on 10 Feb 2010 via Charge ID 10203434 with Union Bank Of India was fully satisfied on 30 Dec 2014. was recorded as a recent event.
The CIN of Raks Pharma Private Limited is U24233GJ2008PTC068526.
Raks Pharma Private Limited is headquartered at 901-911 Iscon Elegance, Opp. Karnavati Club, S.G.Highway,, Ahmedabad, Gujarat, 380015.
Raks Pharma Private Limited was incorporated on 22 October 2008.
The current directors of Raks Pharma Private Limited are
The primary industry of Raks Pharma Private Limited is Manufacturing.
Raks Pharma Private Limited is unlisted.
The authorized capital of Raks Pharma Private Limited is ₹1.75 Cr, and the paid-up capital is ₹1.62 Cr.
The compliance status of Raks Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX